Literature DB >> 35226774

Dynamic contrast-enhanced MRI parametric mapping using high spatiotemporal resolution Golden-angle RAdial Sparse Parallel MRI and iterative joint estimation of the arterial input function and pharmacokinetic parameters.

Yousef Mazaheri1,2, Nathanael Kim1, Yulia Lakhman2, Ramin Jafari1, Alberto Vargas2, Ricardo Otazo1,2.   

Abstract

The aim of this work is to develop a data-driven quantitative dynamic contrast-enhanced (DCE) MRI technique using Golden-angle RAdial Sparse Parallel (GRASP) MRI with high spatial resolution and high flexible temporal resolution and pharmacokinetic (PK) analysis with an arterial input function (AIF) estimated directly from the data obtained from each patient. DCE-MRI was performed on 13 patients with gynecological malignancy using a 3-T MRI scanner with a single continuous golden-angle stack-of-stars acquisition and image reconstruction with two temporal resolutions, by exploiting a unique feature in GRASP that reconstructs acquired data with user-defined temporal resolution. Joint estimation of the AIF (both AIF shape and delay) and PK parameters was performed with an iterative algorithm that alternates between AIF and PK estimation. Computer simulations were performed to determine the accuracy (expressed as percentage error [PE]) and precision of the estimated parameters. PK parameters (volume transfer constant [Ktrans ], fractional volume of the extravascular extracellular space [ve ], and blood plasma volume fraction [vp ]) and normalized root-mean-square error [nRMSE] (%) of the fitting errors for the tumor contrast kinetic data were measured both with population-averaged and data-driven AIFs. On patient data, the Wilcoxon signed-rank test was performed to compare nRMSE. Simulations demonstrated that GRASP image reconstruction with a temporal resolution of 1 s/frame for AIF estimation and 5 s/frame for PK analysis resulted in an absolute PE of less than 5% in the estimation of Ktrans and ve , and less than 11% in the estimation of vp . The nRMSE (mean ± SD) for the dual temporal resolution image reconstruction and data-driven AIF was 0.16 ± 0.04 compared with 0.27 ± 0.10 (p < 0.001) with 1 s/frame using population-averaged AIF, and 0.23 ± 0.07 with 5 s/frame using population-averaged AIF (p < 0.001). We conclude that DCE-MRI data acquired and reconstructed with the GRASP technique at dual temporal resolution can successfully be applied to jointly estimate the AIF and PK parameters from a single acquisition resulting in data-driven AIFs and voxelwise PK parametric maps.
© 2022 John Wiley & Sons, Ltd.

Entities:  

Keywords:  Golden-angle RAdial Sparse Parallel MRI; arterial input function; bolus arrival time; dynamic contrast-enhanced MRI; temporal resolution

Mesh:

Substances:

Year:  2022        PMID: 35226774      PMCID: PMC9203940          DOI: 10.1002/nbm.4718

Source DB:  PubMed          Journal:  NMR Biomed        ISSN: 0952-3480            Impact factor:   4.478


  63 in total

1.  Feasibility of quantitative MR-perfusion imaging to monitor treatment response after uterine artery embolization (UAE) in symptomatic uterus fibroids.

Authors:  Maliha Sadick; Jakob Richers; Benjamin Tuschy; Lothar R Schad; Stefan O Schoenberg; Frank G Zöllner
Journal:  Magn Reson Imaging       Date:  2019-02-23       Impact factor: 2.546

2.  T1 in high-grade glioma and the influence of different measurement strategies on parameter estimations in DCE-MRI.

Authors:  Christopher Larsson; Magne Kleppestø; Inge Grothe; Jonas Vardal; Atle Bjørnerud
Journal:  J Magn Reson Imaging       Date:  2014-10-28       Impact factor: 4.813

3.  A model-constrained Monte Carlo method for blind arterial input function estimation in dynamic contrast-enhanced MRI: II. In vivo results.

Authors:  Matthias C Schabel; Edward V R DiBella; Randy L Jensen; Karen L Salzman
Journal:  Phys Med Biol       Date:  2010-08-03       Impact factor: 3.609

4.  Deterministic Arterial Input Function selection in DCE-MRI for automation of quantitative perfusion calculation of colorectal cancer.

Authors:  Christian Tönnes; Sonja Janssen; Alena-Kathrin Golla; Tanja Uhrig; Khanlian Chung; Lothar R Schad; Frank Gerrit Zöllner
Journal:  Magn Reson Imaging       Date:  2020-09-25       Impact factor: 2.546

5.  Studies of Gd-DTPA relaxivity and proton exchange rates in tissue.

Authors:  K M Donahue; D Burstein; W J Manning; M L Gray
Journal:  Magn Reson Med       Date:  1994-07       Impact factor: 4.668

6.  The derivation of the gamma-variate relationship for tracer dilution curves.

Authors:  R Davenport
Journal:  J Nucl Med       Date:  1983-10       Impact factor: 10.057

7.  Estimating liver perfusion from free-breathing continuously acquired dynamic gadolinium-ethoxybenzyl-diethylenetriamine pentaacetic acid-enhanced acquisition with compressed sensing reconstruction.

Authors:  Hersh Chandarana; Tobias Kai Block; Justin Ream; Artem Mikheev; Samuel H Sigal; Ricardo Otazo; Henry Rusinek
Journal:  Invest Radiol       Date:  2015-02       Impact factor: 6.016

8.  Golden-angle radial sparse parallel MRI: combination of compressed sensing, parallel imaging, and golden-angle radial sampling for fast and flexible dynamic volumetric MRI.

Authors:  Li Feng; Robert Grimm; Kai Tobias Block; Hersh Chandarana; Sungheon Kim; Jian Xu; Leon Axel; Daniel K Sodickson; Ricardo Otazo
Journal:  Magn Reson Med       Date:  2013-10-18       Impact factor: 4.668

9.  Free-Breathing Dynamic Contrast-Enhanced Imaging of the Upper Abdomen Using a Cartesian Compressed-Sensing Sequence With Hard-Gated and Motion-State-Resolved Reconstruction.

Authors:  Daniel Hausmann; Tilo Niemann; Diana Kreul; Antonio Nocito; Markus Klarhöfer; Dominik M Nickel; Berthold Kiefer; Ulrike I Attenberger; Frank G Zöllner; Rahel A Kubik-Huch
Journal:  Invest Radiol       Date:  2019-11       Impact factor: 6.016

10.  Optimization of two-compartment-exchange-model analysis for dynamic contrast-enhanced mri incorporating bolus arrival time.

Authors:  Guy Nadav; Gilad Liberman; Moran Artzi; Nahum Kiryati; Dafna Ben Bashat
Journal:  J Magn Reson Imaging       Date:  2016-07-07       Impact factor: 4.813

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.